Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 12Recruiting 4Unknown 2Terminated 2Not yet recruiting 2Active not recruiting 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 846Carcinoma, Non-Small-Cell Lung 553Neoplasms 516Prostatic Neoplasms 503Lung Neoplasms 312Colorectal Neoplasms 304Multiple Myeloma 295Neoplasm Metastasis 255Melanoma 244Ovarian Neoplasms 215Leukemia, Myeloid, Acute 212Pancreatic Neoplasms 203Squamous Cell Carcinoma of Head and Neck 171Carcinoma, Renal Cell 166Stomach Neoplasms 160Recurrence 159Lymphoma 159Carcinoma, Hepatocellular 159Glioblastoma 151Brain Neoplasms 151Lymphoma, Non-Hodgkin 143Uterine Cervical Neoplasms 142Head and Neck Neoplasms 141Urinary Bladder Neoplasms 137Leukemia, Lymphocytic, Chronic, B-Cell 137Triple Negative Breast Neoplasms 136Precursor Cell Lymphoblastic Leukemia-Lymphoma 132Hematologic Neoplasms 117Colonic Neoplasms 117Lymphoma, Follicular 114

Interventions

Spermine Synthase 1Palliative Care 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Cognition Disorders × Clear all
NCT03606421 2026-03-06

CBF and NCF Changes With Brain Radiation

University Health Network, Toronto

Active not recruiting
110 enrolled
CNS

Brain Neoplasms, Cognition Disorders

NCT04586530 2026-01-21

TAMS

University of Pittsburgh

Phase NA Active not recruiting
220 enrolled

Chemotherapy-Related Cognitive Impairment, Cognition Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡